NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
59 hedge funds and large institutions have $18.1M invested in Niagen Bioscience, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
–
Holders Change %
0%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
16
Reduced
17
Closed
8
Calls
$146K
Puts
$41K
Net Calls
+$105K
Net Calls Change
-$97K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$794K |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
+$454K |
| 3 |
GI
GAMCO Investors
Greenwich,
Connecticut
|
+$270K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$167K |
| 5 |
GF
Gabelli Funds
Rye,
New York
|
+$160K |
Top Sellers
| 1 |
TCM
Tieton Capital Management
Yakima,
Washington
|
-$300K |
| 2 |
Millennium Management
New York
|
-$230K |
| 3 |
Renaissance Technologies
New York
|
-$220K |
| 4 |
Barclays
London,
United Kingdom
|
-$168K |
| 5 |
BlackRock
New York
|
-$127K |
